Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Exclusive Look At Rafarma Pharmaceuticals, Inc. (RAFA), Burgeoning Russian Pharmaceutical Industry

In a QualityStocks Production released today, Rafarma Pharmaceuticals' management explains the company's world class production facility, manufacturing equipment, scientific developments, and its strategy to become a leading pharmaceutical player in the Russian pharmaceutical industry.

"The target of Rafarma is providing a pharmaceutical market, domestic Russian pharmaceutical market, and foreign pharmaceutical markets with pharmaceutical products of the highest quality at affordable prices," Julia Andryshkova, a member of the board of directors of ZAO Rafarma, says in the interview.

CEO Sergey Brunsnitsyn explains the construction, engineering, maintenance, and capabilities of the plant, as well as its overarching production goals.

"The program aims for developing of modern high-performance industrial and production basis corresponding to the GMP standards that will provide highly competitive domestic products for both internal and external markets," he says.

The video includes interviews from several individuals on the company's management team as well as plant employees.

To watch the entire video, visit videos.qualitystocks.net

For more information on Rafarma, visit rafarma.com

Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net